Meetings
P-06-1550 Place the drug Xonvea on to the formulary for the management of nausea and vomiting in pregnancy
This page gives details of any meetings held which will, or did, discuss the matter, and includes links to the relevant Papers, Agendas and Minutes.
Note: Meeting Agenda can change at short notice. Particularly where future meeting dates are indicated more than a week in advance. Please check before planning to attend a Committee Meeting that the item you are interested in has not been moved.
Meeting: 16/03/2026 - Petitions Committee (Item 6.1)
6.1 P-06-1550 Place the drug Xonvea on to the formulary for the management of nausea and vomiting in pregnancy
Supporting documents:
Meeting: 09/02/2026 - Petitions Committee (Item 3)
3 P-06-1550 Place the drug Xonvea on to the formulary for the management of nausea and vomiting in pregnancy
Supporting documents:
- Cover sheet, item 3
PDF 42 KB
View as HTML (3/1) 7 KB
- Correspondence from the All Wales Medicines Strategy Group, 21 January 2026, item 3
PDF 407 KB
- Correspondence from Petitioner, 2 February 2026, item 3
PDF 209 KB
View as HTML (3/3) 21 KB
Minutes:
This was a very emotive issue and the committee had heard the cases of women who had terminated their pregnancy as a result of HG. It was agreed to forward the petitioner’s additional detailed questions to the AWMSG, along with information the Chair had received about a case of access to the drug being complicated and difficult. Members agreed to keep the petition open until a response was received, noting that this could be in the Seventh Senedd.
Meeting: 15/01/2026 - Health and Social Care Committee (Item 3)
- Webcast for 15/01/2026 - Health and Social Care Committee
- Transcript for 15/01/2026 - Health and Social Care Committee
3 Letter from the Petitions Committee re petition P-06-1550: Place the drug Xonvea on to the formulary for the management of nausea and vomiting in pregnancy
Supporting documents:
Minutes:
3.3.1 The Committee noted the letter.
Meeting: 08/12/2025 - Petitions Committee (Item 2)
2 P-06-1550 Place the drug Xonvea on to the formulary for the management of nausea and vomiting in pregnancy
Supporting documents:
- Research brief, item 2
PDF 319 KB
View as HTML (2/1) 41 KB
- Correspondence from the Cabinet Secretary for Health and Social Care, 06 November 2025, item 2
PDF 171 KB
- Correspondence from the Petitioner, 29 November 2025, item 2
PDF 2 MB
- Correspondence from the Petitioner, 29 November 2025 (Restricted)
Minutes:
The Committee considered the petition and took a moment to recognise the women who had shared their distressing experiences of Hyperemesis Gravidarum (HG) and the impact on their families.
Members agreed to write to the All Wales Medicines Strategy Group (AWMSG) to strongly urge it to reconsider the earlier decision and keep looking at this issue, highlighting the petitioners’ evidence and emphasising that cost should not be the determining factor.
The Committee also agreed to share all the evidence provided by the petitioners on prescribing Xonvea and maternal health more broadly, with the Chair of the Health and Social Care Committee.
The petition will remain open pending a response from the
AWMSG.